Characterisation of a novel Respiratory Syncytial Virus (RSV) immune evasion mechanism and evaluation of the impact for development of novel vaccines and prophylactic and/or therapeutic antibodies
Mechanism of infection of sialoadhesin (Sn)-positive macrophages with respiratory syncytial virus (RSV) and its implications for inflammation and immune pathology during bronchiolitis.
Improved respiratory syncytial virus (rsv) vaccines based on glycan modification of the viral fusion (f) protein.
Elucidating the role of the Respiratory Syncytial Virus (RSV) peptide p27 and N-glycans in this peptide in protein structure and protective antibody responses.
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice
Multi-country economic evaluations of interventions against Respiratory Syncytial Virus (RSV) and influenza-like illness (ILI)
Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya